Patrick Serruys

Showing 1-20 of 528 articles

Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Münzel T, Cequier A, Buono A, Serruys P, Sabaté M

March 20, 2020 | 10.4244/EIJ-D-19-00773

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data

Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz K, Windecker S, Kastrati A, Serruys P

March 20, 2020 | 10.4244/EIJ-D-18-01080

Coronary interventions

The year in review 2019: Coronary interventions

Gao C, Wang R, Sharif F, Takahashi K, Ono M, Hara H, Tomaniak M, Kawashima H, Modolo R, van Geuns R, Capodanno D, Byrne R, Wijns W, Onuma Y, Serruys P

February 25, 2020 | 10.4244/EIJ-D-19-01124

Coronary interventions

Absorb Bioresorbable Vascular Scaffold is Associated with Low Wall Shear Stress Compared to Xience V: A Biomechanical Analysis of the Absorb III Imaging Study.

Kumar A, Gogas B, Thompson EW, Burnett GM, Molony D, Hosseini H, Chandran K, Lefieux A, Honda Y, Lee J, Serruys P, Kereiakes DJ, Stone GW, Samady H, Raad M, Gupta S, Sternheim DG, Okada K, Rapoza RJ, Simonton C, Giddens DP, Veneziani A, King III S, Ellis SG

February 23, 2020 | 10.4244/EIJ-D-19-01128

Feasibility of quantitative assessment of aortic regurgitation in a percutaneous closure of paravalvular leak: expanding videodensitometry

Teixeirense P, Modolo R, de Toledo J, Serruys P

February 20, 2020 | 10.4244/EIJ-D-19-00118

Sustained safety and efficacy of the magnesium scaffold: does the Magmaris scaffold call for the return of BRS research… and randomised controlled trials?

Onuma Y, Serruys P

February 7, 2020 | 10.4244/EIJV15I15A238

Coronary interventions

Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial

Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek J, Wykrzykowska J, Asano T, Kogame N, Takahashi K, Chang C, de Winter R, Serruys P, Wijns W

February 7, 2020 | 10.4244/EIJ-D-18-00944

Coronary interventions

Impact of clinical and hemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries - A patient level pooled analysis of the DEBATE and ILIAS studies

Stegehuis VE, Wijntjens GW, Bax M, Meuwissen M, Chamuleau SA, Voskuil M, Koch K, Di Mario C, Vrints C, Haude M, Boersma E, Serruys P, Piek J, van de Hoef T

January 21, 2020 | 10.4244/EIJ-D-19-00774

Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?

Tomaniak M, Storey R, Serruys P

January 17, 2020 | 10.4244/EIJY19M10_01

Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Chang C, Kogame N, Onuma Y, Byrne R, Capodanno D, Windecker S, Morel M, Cutlip D, Krucoff M, Stone GW, Lansky A, Mehran R, Spitzer E, Fraser A, Baumbach A, Serruys P

January 17, 2020 | 10.4244/EIJ-D-19-00552

Coronary interventions

The obesity paradox revisited: body mass index and long-term outcomes after PCI from a large pooled patient-level database

Wolny R, Maehara A, Liu Y, Zhang Z, Mintz G, Redfors B, Madhavan M, Smits P, von Birgelen C, Serruys P, Mehran R, Leon M, Stone GW

January 17, 2020 | 10.4244/EIJ-D-19-00467

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

December 20, 2019 | 10.4244/EIJ-D-19-00202

Coronary interventions

Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang C, Kogame N, Spitzer E, Buszman P, van Geuns R, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabaté M, Zmudka K, Rademaker-Havinga T, Tijssen J, Jüni P, Hamm C, Steg G, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys P

December 17, 2019 | 10.4244/EIJ-D-19-00699

Coronary interventions

Procedural Characteristics and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Left Main Trifurcation Disease: The EXCEL trial

Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik III JF, Kappetein AP, Dressler O, Stone GW

December 3, 2019 | 10.4244/EIJ-D-19-00686

Coronary interventions

Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial

Kini A, Dangas G, Baber U, Vengrenyuk Y, Kandzari D, Leon M, Morice M, Serruys P, Kappetein AP, Sabik III JF, Dressler O, Mehran R, Sharma SK, Stone GW

November 26, 2019 | 10.4244/EIJ-D-19-00851

Interventions for valvular disease

Quantitative aortography assessment of aortic regurgitation. Insight into a novel technique

Modolo R, Chang C, Onuma Y, Schultz C, Tateishi H, Abdelghani M, Miyazaki Y, Aben J-P, Rutten M, Pighi M, El Bouziani A, van Mourik M, Lemos P, Wykrzykowska J, Sandoli de Brito Jr F, Sahyoun C, Piazza N, Eltchaninoff H, Soliman O, Abdel-Wahab M, Van Mieghem N, de Winter R, Serruys P

November 20, 2019 | 10.4244/EIJ-D-19-00879

Coronary interventions

Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

November 20, 2019 | 10.4244/EIJ-D-19-00866

The SYNTAX score on its way out or … towards artificial intelligence: part II

Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls N, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarría-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone GW, Onuma Y

October 25, 2019 | 10.4244/EIJ-D-19-00543B

The SYNTAX score on its way out or … towards artificial intelligence: part I

October 25, 2019 | 10.4244/EIJ-D-19-00543A

The EuroIntervention health check 2019

Mylotte D, Byrne R, Capodanno D, Søndergaard L, Vahanian A, Serruys P

October 4, 2019 | 10.4244/EIJV15I9A135

Latest news

NEW ISSUE

"Shocktopics” with intravascular lithotripsy, bioprosthetic valve fracture, myocardial fibrosis in TAVI...

Reimaged models and angiograms showing CO March 17, 2020

March 20, 2020

JAA

New ahead of print: Infolding of self expanding valve during transcatheter aortic valve implantation

Nandhakumar Vasu et al

March 24, 2020

Editorial

Bioresorbable scaffolds and STEMI: an ideal setting, but still vacant

Christian Spaulding

March 20, 2020

Trials Book

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

Defining procedural MI - does it matter (spoiler alert - it does!)

Gregg W Stone

March 24, 2020

JAA

This week’s JAA’s: QFR in severe AS & Infection control for TAVI

March 24, 2020

Patrick Serruys

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke